Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry

Fig. 1

Flow of patients through the study. Patients were included in the Corrona RA registry cohort study if they initiated therapy with a csDMARD monotherapy, a biologic monotherapy, or combination therapy of a csDMARD plus a biologic between January 1, 2004, and December 31, 2015; after enrollment in the Corrona RA registry had at least 6 months of follow-up time after the index date; and had at least one follow-up visit. Patient cohorts were defined by the first treatment initiation after enrollment into Corrona and were mutually exclusive. DMARD, disease-modifying antirheumatic drug; RA, rheumatoid arthritis

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us